BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 36940215)

  • 1. 11β-HSD1 inhibition does not affect murine tumour angiogenesis but may exert a selective effect on tumour growth by modulating inflammation and fibrosis.
    Davidson CT; Miller E; Muir M; Dawson JC; Lee M; Aitken S; Serrels A; Webster SP; Homer NZM; Andrew R; Brunton VG; Hadoke PWF; Walker BR
    PLoS One; 2023; 18(3):e0255709. PubMed ID: 36940215
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantification of 11β-hydroxysteroid dehydrogenase 1 kinetics and pharmacodynamic effects of inhibitors in brain using mass spectrometry imaging and stable-isotope tracers in mice.
    Cobice DF; Livingstone DEW; McBride A; MacKay CL; Walker BR; Webster SP; Andrew R
    Biochem Pharmacol; 2018 Feb; 148():88-99. PubMed ID: 29248595
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Contribution of endogenous glucocorticoids and their intravascular metabolism by 11β-HSDs to postangioplasty neointimal proliferation in mice.
    Iqbal J; Macdonald LJ; Low L; Seckl JR; Yau CW; Walker BR; Hadoke PW
    Endocrinology; 2012 Dec; 153(12):5896-905. PubMed ID: 23125311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In obese mice, exercise training increases 11β-HSD1 expression, contributing to glucocorticoid activation and suppression of pulmonary inflammation.
    Du SF; Yu Q; Chuan K; Ye CL; He ZJ; Liu SJ; Zhu XY; Liu YJ
    J Appl Physiol (1985); 2017 Oct; 123(4):717-727. PubMed ID: 28663379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Macrophage 11β-HSD-1 deficiency promotes inflammatory angiogenesis.
    Zhang Z; Coutinho AE; Man TY; Kipari TMJ; Hadoke PWF; Salter DM; Seckl JR; Chapman KE
    J Endocrinol; 2017 Sep; 234(3):291-299. PubMed ID: 28676523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. BVT.2733, a selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, attenuates obesity and inflammation in diet-induced obese mice.
    Wang L; Liu J; Zhang A; Cheng P; Zhang X; Lv S; Wu L; Yu J; Di W; Zha J; Kong X; Qi H; Zhong Y; Ding G
    PLoS One; 2012; 7(7):e40056. PubMed ID: 22768329
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Topical 11β-Hydroxysteroid Dehydrogenase Type 1 Inhibition Corrects Cutaneous Features of Systemic Glucocorticoid Excess in Female Mice.
    Tiganescu A; Hupe M; Uchida Y; Mauro T; Elias PM; Holleran WM
    Endocrinology; 2018 Jan; 159(1):547-556. PubMed ID: 29087473
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiomyocyte and Vascular Smooth Muscle-Independent 11β-Hydroxysteroid Dehydrogenase 1 Amplifies Infarct Expansion, Hypertrophy, and the Development of Heart Failure After Myocardial Infarction in Male Mice.
    White CI; Jansen MA; McGregor K; Mylonas KJ; Richardson RV; Thomson A; Moran CM; Seckl JR; Walker BR; Chapman KE; Gray GA
    Endocrinology; 2016 Jan; 157(1):346-57. PubMed ID: 26465199
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific glucocorticoid reactivating enzyme, 11 beta-hydroxysteroid dehydrogenase type 1 (11 beta-HSD1)--a promising drug target for the treatment of metabolic syndrome.
    Masuzaki H; Flier JS
    Curr Drug Targets Immune Endocr Metabol Disord; 2003 Dec; 3(4):255-62. PubMed ID: 14683456
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Short-term inhibition of 11β-hydroxysteroid dehydrogenase type 1 reversibly improves spatial memory but persistently impairs contextual fear memory in aged mice.
    Wheelan N; Webster SP; Kenyon CJ; Caughey S; Walker BR; Holmes MC; Seckl JR; Yau JL
    Neuropharmacology; 2015 Apr; 91():71-6. PubMed ID: 25497454
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Changing glucocorticoid action: 11β-hydroxysteroid dehydrogenase type 1 in acute and chronic inflammation.
    Chapman KE; Coutinho AE; Zhang Z; Kipari T; Savill JS; Seckl JR
    J Steroid Biochem Mol Biol; 2013 Sep; 137():82-92. PubMed ID: 23435016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 11beta-Hydroxysteroid dehydrogenase type 1 regulates insulin and glucagon secretion in pancreatic islets.
    Swali A; Walker EA; Lavery GG; Tomlinson JW; Stewart PM
    Diabetologia; 2008 Nov; 51(11):2003-11. PubMed ID: 18779947
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 11β-Hydroxysteroid dehydrogenase type 1 selective inhibitor BVT.2733 protects osteoblasts against endogenous glucocorticoid induced dysfunction.
    Wu L; Qi H; Zhong Y; Lv S; Yu J; Liu J; Wang L; Bi J; Kong X; Di W; Zha J; Liu F; Ding G
    Endocr J; 2013; 60(9):1047-58. PubMed ID: 23759754
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genistein inhibits glucocorticoid amplification in adipose tissue by suppression of 11β-hydroxysteroid dehydrogenase type 1.
    Tagawa N; Kubota S; Kobayashi Y; Kato I
    Steroids; 2015 Jan; 93():77-86. PubMed ID: 25447798
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibiting 11β-hydroxysteroid dehydrogenase type 1 prevents stress effects on hippocampal synaptic plasticity and impairs contextual fear conditioning.
    Sarabdjitsingh RA; Zhou M; Yau JL; Webster SP; Walker BR; Seckl JR; Joëls M; Krugers HJ
    Neuropharmacology; 2014 Jun; 81():231-6. PubMed ID: 24495397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 11β-hydroxysteroid dehydrogenase type 1 deficiency in bone marrow-derived cells reduces atherosclerosis.
    Kipari T; Hadoke PW; Iqbal J; Man TY; Miller E; Coutinho AE; Zhang Z; Sullivan KM; Mitic T; Livingstone DE; Schrecker C; Samuel K; White CI; Bouhlel MA; Chinetti-Gbaguidi G; Staels B; Andrew R; Walker BR; Savill JS; Chapman KE; Seckl JR
    FASEB J; 2013 Apr; 27(4):1519-31. PubMed ID: 23303209
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Decreased 11β-hydroxysteroid dehydrogenase 1 in lungs of steroid receptor coactivator (Src)-1/-2 double-deficient fetal mice is caused by impaired glucocorticoid and cytokine signaling.
    Chen J; Mishra R; Yu Y; McDonald JG; Eckert KM; Gao L; Mendelson CR
    FASEB J; 2020 Dec; 34(12):16243-16261. PubMed ID: 33070362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Local amplification of glucocorticoids by 11beta-hydroxysteroid dehydrogenase type 1 and its role in the inflammatory response.
    Chapman KE; Coutinho A; Gray M; Gilmour JS; Savill JS; Seckl JR
    Ann N Y Acad Sci; 2006 Nov; 1088():265-73. PubMed ID: 17192572
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reciprocal regulation of 11β-hydroxysteroid dehydrogenase 1 and glucocorticoid receptor expression by dexamethasone inhibits human coronary artery smooth muscle cell proliferation in vitro.
    Michas G; Liberman M; Becker KC; Handy DE; Loscalzo J; Leopold JA
    Mol Cell Biochem; 2011 Jan; 346(1-2):69-79. PubMed ID: 20922465
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Local steroid activation is a critical mediator of the anti-inflammatory actions of therapeutic glucocorticoids.
    Fenton C; Martin C; Jones R; Croft A; Campos J; Naylor AJ; Taylor AE; Chimen M; Cooper M; Lavery GG; Raza K; Hardy RS
    Ann Rheum Dis; 2021 Feb; 80(2):250-260. PubMed ID: 33162397
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.